Global Thoracolumbar Spine Devices Market Research Report—Forecast till 2025
出 版 商：Market Research Future
出版日期：2020/12/01
頁 數：156頁
文件格式：PDF
價 格：
USD 4,450 (Single-User License)
USD 6,250 (Global-User License)
USD 6,250 (Global-User License)
Global Thoracolumbar Spine Devices Market: Information by Product Type (Spinal implants, Devices and Instrumentation and Spine Biologics), By Type of Surgery (Open Surgery and Minimally Invasive Surgery (MIS)), by Material (Titanium, Stainless Steel, Biomaterials and others), By End User (Hospitals and Clinics, Ambulatory Surgery Centers, Academic Institutes and Research Centers and others) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025
Market analysis
Generally, the increasing obese population, high prevalence of spinal cord injuries (SCI), and increasing geriatric population are expected to enhance market growth. Nevertheless, the stringent regulatory policies, lack of awareness for the use of advanced technologies, and product recalls are projected to curb the growth of the market. Thoracolumbar Spine Devices Market is expected to register a CAGR of 3.72% to reach USD 8,484.7 Million by 2025. Thoracolumbar junction is the junction between the thoracic spine and the lumbar spine. The junction involves of the part of the vertebral column from the eleventh thoracic vertebra to the first lumbar vertebra. Thoracolumbar spine devices are used in this region to deliver steady support to the spine and avert bending of the thoracic spine.
Market segmentation
The Global thoracolumbar spine devices market, by product type, has been segmented into spinal implants, devices and instrumentation and spine biologics respectively. Corresponding to a study published by the National Spinal Cord Injury Statistical Center in 2019, the annual incidence of SCI is approximately 54 per million people in the US or around 17,730 new cases each year. The approximate number of individuals affected by SCI in the US is 291,000. High prevalence of spinal cord injuries, in turn, increases the demand for thoracolumbar spine devices used in analysis. Thus, an increase in the prevalence of spinal cord injuries is expected to boost the global thoracolumbar spine devices market for the duration of the forecast period. The market is expected to witness a profitable growth owing to the high prevalence of spinal cord injuries (SCI). Based on the type of surgery, the thoracolumbar spine devices market has been categorized as open surgery and minimally invasive surgery (MIS). The material segment is further segmented as titanium, stainless steel, biomaterials, and others. Based on end-user, the thoracolumbar spine devices market has been grouped as hospitals and clinics, ambulatory surgery centers, academic institutions and research centers, and others.
Regional analysis
Geographically the Global thoracolumbar spine devices market is split in regions like North & South America, Europe, Asia-Pacific, Middle east and Africa and Rest of the world. Europe is anticipated to account for the second-largest market share during the forecast period. The market expansion in Europe can be attributed to the research and development by manufacturers for the launch of innovative products. For instance, ZygoFix Ltd, in 2018, initiated the first in a human clinical study for its clock spinal facet joint fixation system. Americas settled for the largest market share of in 2018, due to the presence of key market players, sophisticated healthcare infrastructure, and increasing R&D in the field of thoracolumbar spine devices. Asia-Pacific is likely to be the fastest-growing region in the global thoracolumbar spine devices market. The high growth rate is due to owing to the presence of a large patient base, availability of skilled healthcare personnel, and a defined regulatory framework facilitating enhanced product approvals. India held a share of 16.2% in the Asia-Pacific thoracolumbar spine devices market in 2018. The Middle East & Africa market is projected to show gradual growth during the forecast period. The Middle East would spearhead the market growth, attributing to facts such as the developing healthcare transportation, booming medical tourism, budding medical device industry, and gradually expanding adoption of medical analysis modalities in the Gulf Cooperation Council (GCC).
Major players
The proposed spectators in the Global thoracolumbar spine devices market are manufacturers, Retailers, distributors, wholesalers, Investors and trade experts, Governments, associations, industrial bodies, etc. The major companies functioning in the Global thoracolumbar spine devices market are concentrating on firming their global ways by entering into untouched markets. The projected onlookers in the Global thoracolumbar spine devices market are companies like Alphatech holdings, Inc. (US), B. Braun Melsungen AG (Germany), Depuy Synthes (US), Exactech, Inc. (US), Orthofix Holdings, Inc. (US), Globus Medical, Inc. (US), Medtronic PLC (Ireland), NuVasive, Inc. (US), Zimmer Biomet holdings, Inc. (US), Stryker corporation (US) and Globus Medical, Inc. (US),
Market analysis
Generally, the increasing obese population, high prevalence of spinal cord injuries (SCI), and increasing geriatric population are expected to enhance market growth. Nevertheless, the stringent regulatory policies, lack of awareness for the use of advanced technologies, and product recalls are projected to curb the growth of the market. Thoracolumbar Spine Devices Market is expected to register a CAGR of 3.72% to reach USD 8,484.7 Million by 2025. Thoracolumbar junction is the junction between the thoracic spine and the lumbar spine. The junction involves of the part of the vertebral column from the eleventh thoracic vertebra to the first lumbar vertebra. Thoracolumbar spine devices are used in this region to deliver steady support to the spine and avert bending of the thoracic spine.
Market segmentation
The Global thoracolumbar spine devices market, by product type, has been segmented into spinal implants, devices and instrumentation and spine biologics respectively. Corresponding to a study published by the National Spinal Cord Injury Statistical Center in 2019, the annual incidence of SCI is approximately 54 per million people in the US or around 17,730 new cases each year. The approximate number of individuals affected by SCI in the US is 291,000. High prevalence of spinal cord injuries, in turn, increases the demand for thoracolumbar spine devices used in analysis. Thus, an increase in the prevalence of spinal cord injuries is expected to boost the global thoracolumbar spine devices market for the duration of the forecast period. The market is expected to witness a profitable growth owing to the high prevalence of spinal cord injuries (SCI). Based on the type of surgery, the thoracolumbar spine devices market has been categorized as open surgery and minimally invasive surgery (MIS). The material segment is further segmented as titanium, stainless steel, biomaterials, and others. Based on end-user, the thoracolumbar spine devices market has been grouped as hospitals and clinics, ambulatory surgery centers, academic institutions and research centers, and others.
Regional analysis
Geographically the Global thoracolumbar spine devices market is split in regions like North & South America, Europe, Asia-Pacific, Middle east and Africa and Rest of the world. Europe is anticipated to account for the second-largest market share during the forecast period. The market expansion in Europe can be attributed to the research and development by manufacturers for the launch of innovative products. For instance, ZygoFix Ltd, in 2018, initiated the first in a human clinical study for its clock spinal facet joint fixation system. Americas settled for the largest market share of in 2018, due to the presence of key market players, sophisticated healthcare infrastructure, and increasing R&D in the field of thoracolumbar spine devices. Asia-Pacific is likely to be the fastest-growing region in the global thoracolumbar spine devices market. The high growth rate is due to owing to the presence of a large patient base, availability of skilled healthcare personnel, and a defined regulatory framework facilitating enhanced product approvals. India held a share of 16.2% in the Asia-Pacific thoracolumbar spine devices market in 2018. The Middle East & Africa market is projected to show gradual growth during the forecast period. The Middle East would spearhead the market growth, attributing to facts such as the developing healthcare transportation, booming medical tourism, budding medical device industry, and gradually expanding adoption of medical analysis modalities in the Gulf Cooperation Council (GCC).
Major players
The proposed spectators in the Global thoracolumbar spine devices market are manufacturers, Retailers, distributors, wholesalers, Investors and trade experts, Governments, associations, industrial bodies, etc. The major companies functioning in the Global thoracolumbar spine devices market are concentrating on firming their global ways by entering into untouched markets. The projected onlookers in the Global thoracolumbar spine devices market are companies like Alphatech holdings, Inc. (US), B. Braun Melsungen AG (Germany), Depuy Synthes (US), Exactech, Inc. (US), Orthofix Holdings, Inc. (US), Globus Medical, Inc. (US), Medtronic PLC (Ireland), NuVasive, Inc. (US), Zimmer Biomet holdings, Inc. (US), Stryker corporation (US) and Globus Medical, Inc. (US),
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 MARKET SYNOPSIS 16
1.2 KEY CONTRIBUTING FACTORS 17
1.3 MARKET ATTRACTIVENESS ANALYSIS 18
1.4 GLOBAL THORACOLUMBAR SPINE DEVICES MARKET, BY PRODUCT TYPE 19
1.5 GLOBAL THORACOLUMBAR SPINE DEVICES MARKET, BY TYPE OF SURGERY 20
1.6 GLOBAL THORACOLUMBAR SPINE DEVICES MARKET, BY MATERIAL 21
1.7 GLOBAL THORACOLUMBAR SPINE DEVICES MARKET, BY END USER 22
2 Market Introduction
2.1 DEFINITION 23
2.2 SCOPE OF THE STUDY 23
2.3 RESEARCH OBJECTIVE 23
2.4 MARKET STRUCTURE 24
2.5 ASSUMPTIONS & LIMITATIONS 24
3 Research Methodology
3.1 DATA MINING 25
3.2 SECONDARY RESEARCH 26
3.3 PRIMARY RESEARCH 27
3.4 BREAKDOWN OF PRIMARY RESPONDENTS 28
3.5 FORECASTING TECHNIQUES 29
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 30
3.6.1 BOTTOM-UP APPROACH 31
3.6.2 TOP-DOWN APPROACH 31
3.7 DATA TRIANGULATION 32
3.8 VALIDATION 32
4 MARKET DYNAMICS
4.1 OVERVIEW 33
4.2 DRIVERS 34
4.2.1 INCREASING OBESE POPULATION 34
4.2.2 HIGH PREVALENCE OF SPINAL CORD INJURIES (SCI) 34
4.2.3 INCREASING GERIATRIC POPULATION 34
4.3 RESTRAINTS 35
4.3.1 STRINGENT REGULATORY POLICIES 35
4.3.2 LACK OF AWARENESS FOR THE USE OF ADVANCED TECHNOLOGIES 35
4.3.3 PRODUCT RECALLS 35
4.4 OPPORTUNITIES 36
4.4.1 LAUNCH OF INNOVATIVE PRODUCTS 36
5 MARKET FACTOR ANALYSIS
5.1 PORTER’S FIVE FORCES MODEL 37
5.1.1 BARGAINING POWER OF SUPPLIERS 38
5.1.2 BARGAINING POWER OF BUYERS 38
5.1.3 THREAT OF NEW ENTRANTS 38
5.1.4 THREAT OF SUBSTITUTES 38
5.1.5 INTENSITY OF RIVALRY 38
5.2 VALUE CHAIN ANALYSIS 39
5.2.1 R&D AND DESIGNING 40
5.2.2 MANUFACTURING 40
5.2.3 DISTRIBUTION & SALES 40
5.2.4 POST-SALES REVIEW 40
5.3 INVESTMENT OPPORTUNITIES 41
6 GLOBAL THORACOLUMBAR SPINE DEVICES MARKET, BY PRODUCT TYPE
6.1 OVERVIEW 42
6.2 SPINAL IMPLANTS 44
6.3 DEVICES AND INSTRUMENTATION 44
6.4 SPINE BIOLOGICS 45
7 GLOBAL THORACOLUMBAR SPINE DEVICES MARKET, BY TYPE OF SURGERY
7.1 OVERVIEW 46
7.2 OPEN SURGERY 48
7.3 MINIMALLY INVASIVE SURGERY (MIS) 49
8 GLOBAL THORACOLUMBAR SPINE DEVICES MARKET, BY MATERIAL
8.1 OVERVIEW 50
8.2 TITANIUM 51
8.3 STAINLESS STEEL 52
8.4 BIOMATERIALS 53
8.5 OTHERS 53
9 GLOBAL THORACOLUMBAR SPINE DEVICES MARKET, BY END USER
9.1 OVERVIEW 54
9.2 HOSPITALS AND CLINICS 55
9.3 AMBULATORY SURGERY CENTERS 56
9.4 ACADEMIC INSTITUTES AND RESEARCH CENTERS 56
9.5 OTHERS 56
10 GLOBAL THORACOLUMBAR SPINE DEVICES MARKET, BY REGION
10.1 OVERVIEW 57
10.2 AMERICAS 59
10.2.1 NORTH AMERICA 61
10.2.2 LATIN AMERICA 66
10.3 EUROPE 68
10.3.1 WESTERN EUROPE 70
10.3.2 EASTERN EUROPE 80
10.4 ASIA-PACIFIC 82
10.4.1 JAPAN 84
10.4.2 CHINA 86
10.4.3 INDIA 87
10.4.4 SOUTH KOREA 88
10.4.5 AUSTRALIA 90
10.4.6 REST OF ASIA-PACIFIC 91
10.5 MIDDLE EAST & AFRICA 93
10.5.1 MIDDLE EAST 95
10.5.2 AFRICA 96
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW 98
11.2 COMPANY RANKING 98
11.3 COMPETITIVE BENCHMARKING 100
11.4 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE THORACOLUMBAR SPINE DEVICES MARKET 101
11.5 KEY DEVELOPMENT ANALYSIS 101
11.1 KEY DEVELOPMENTS & GROWTH STRATEGIES 102
11.1.1 NEW PRODUCT LAUNCH/APPROVAL 102
11.1.2 MERGERS & ACQUISITIONS 103
12 COMPANY PROFILES
12.1 ORTHOFIX HOLDINGS, INC. 104
12.1.1 COMPANY OVERVIEW 104
12.1.2 FINANCIAL OVERVIEW 105
12.1.3 PRODUCTS/SERVICES OFFERED 106
12.1.4 KEY DEVELOPMENTS 106
12.1.5 SWOT ANALYSIS 107
12.1.6 KEY STRATEGIES 107
12.2 ALPHATECH HOLDINGS, INC. 108
12.2.1 COMPANY OVERVIEW 108
12.2.2 FINANCIAL OVERVIEW 109
12.2.3 PRODUCTS/SERVICES OFFERED 109
12.2.4 KEY DEVELOPMENTS 110
12.2.5 SWOT ANALYSIS 110
12.2.6 KEY STRATEGIES 111
12.3 B. BRAUN MELSUNGEN AG 112
12.3.1 COMPANY OVERVIEW 112
12.3.2 FINANCIAL OVERVIEW 112
12.3.3 PRODUCTS/SERVICES OFFERED 113
12.3.4 KEY DEVELOPMENTS 113
12.3.5 SWOT ANALYSIS 114
12.3.6 KEY STRATEGIES 114
12.4 DEPUY SYNTHES 115
12.4.1 COMPANY OVERVIEW 115
12.4.2 FINANCIAL OVERVIEW 115
12.4.3 PRODUCTS/SERVICES OFFERED 116
12.4.4 KEY DEVELOPMENTS 116
12.4.5 SWOT ANALYSIS 117
12.4.6 KEY STRATEGIES 117
12.5 EXACTECH, INC. 118
12.5.1 COMPANY OVERVIEW 118
12.5.2 FINANCIAL OVERVIEW 118
12.5.3 PRODUCTS/SERVICES OFFERED 119
12.5.4 KEY DEVELOPMENTS 119
12.5.5 SWOT ANALYSIS 120
12.5.6 KEY STRATEGIES 120
12.6 GLOBUS MEDICAL, INC. 121
12.6.1 COMPANY OVERVIEW 121
12.6.2 FINANCIAL OVERVIEW 121
12.6.3 PRODUCTS/SERVICES OFFERED 122
12.6.4 KEY DEVELOPMENTS 122
12.6.5 SWOT ANALYSIS 123
12.6.6 KEY STRATEGIES 123
12.7 MEDTRONIC PLC 124
12.7.1 COMPANY OVERVIEW 124
12.7.2 FINANCIAL OVERVIEW 125
12.7.3 PRODUCTS/SERVICES OFFERED 125
12.7.4 KEY DEVELOPMENTS 126
12.7.5 SWOT ANALYSIS 126
12.7.6 KEY STRATEGIES 127
12.8 NUVASIVE, INC. 128
12.8.1 COMPANY OVERVIEW 128
12.8.2 FINANCIAL OVERVIEW 129
12.8.3 PRODUCTS/SERVICES OFFERED 129
12.8.4 KEY DEVELOPMENTS 130
12.8.5 SWOT ANALYSIS 130
12.8.6 KEY STRATEGIES 130
12.9 ZIMMER BIOMET HOLDINGS, INC. 131
12.9.1 COMPANY OVERVIEW 131
12.9.2 FINANCIAL OVERVIEW 132
12.9.3 PRODUCTS/SERVICES OFFERED 133
12.9.4 KEY DEVELOPMENTS 133
12.9.5 SWOT ANALYSIS 134
12.9.6 KEY STRATEGIES 134
12.10 STRYKER CORPORATION 135
12.10.1 COMPANY OVERVIEW 135
12.10.2 FINANCIAL OVERVIEW 136
12.10.3 PRODUCTS/SERVICES OFFERED 137
12.10.4 KEY DEVELOPMENTS 137
12.10.5 SWOT ANALYSIS 138
12.10.6 KEY STRATEGIES 138
13 APPENDIX
13.1 REFERENCES 139
13.2 RELATED REPORTS 139
1 EXECUTIVE SUMMARY
1.1 MARKET SYNOPSIS 16
1.2 KEY CONTRIBUTING FACTORS 17
1.3 MARKET ATTRACTIVENESS ANALYSIS 18
1.4 GLOBAL THORACOLUMBAR SPINE DEVICES MARKET, BY PRODUCT TYPE 19
1.5 GLOBAL THORACOLUMBAR SPINE DEVICES MARKET, BY TYPE OF SURGERY 20
1.6 GLOBAL THORACOLUMBAR SPINE DEVICES MARKET, BY MATERIAL 21
1.7 GLOBAL THORACOLUMBAR SPINE DEVICES MARKET, BY END USER 22
2 Market Introduction
2.1 DEFINITION 23
2.2 SCOPE OF THE STUDY 23
2.3 RESEARCH OBJECTIVE 23
2.4 MARKET STRUCTURE 24
2.5 ASSUMPTIONS & LIMITATIONS 24
3 Research Methodology
3.1 DATA MINING 25
3.2 SECONDARY RESEARCH 26
3.3 PRIMARY RESEARCH 27
3.4 BREAKDOWN OF PRIMARY RESPONDENTS 28
3.5 FORECASTING TECHNIQUES 29
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 30
3.6.1 BOTTOM-UP APPROACH 31
3.6.2 TOP-DOWN APPROACH 31
3.7 DATA TRIANGULATION 32
3.8 VALIDATION 32
4 MARKET DYNAMICS
4.1 OVERVIEW 33
4.2 DRIVERS 34
4.2.1 INCREASING OBESE POPULATION 34
4.2.2 HIGH PREVALENCE OF SPINAL CORD INJURIES (SCI) 34
4.2.3 INCREASING GERIATRIC POPULATION 34
4.3 RESTRAINTS 35
4.3.1 STRINGENT REGULATORY POLICIES 35
4.3.2 LACK OF AWARENESS FOR THE USE OF ADVANCED TECHNOLOGIES 35
4.3.3 PRODUCT RECALLS 35
4.4 OPPORTUNITIES 36
4.4.1 LAUNCH OF INNOVATIVE PRODUCTS 36
5 MARKET FACTOR ANALYSIS
5.1 PORTER’S FIVE FORCES MODEL 37
5.1.1 BARGAINING POWER OF SUPPLIERS 38
5.1.2 BARGAINING POWER OF BUYERS 38
5.1.3 THREAT OF NEW ENTRANTS 38
5.1.4 THREAT OF SUBSTITUTES 38
5.1.5 INTENSITY OF RIVALRY 38
5.2 VALUE CHAIN ANALYSIS 39
5.2.1 R&D AND DESIGNING 40
5.2.2 MANUFACTURING 40
5.2.3 DISTRIBUTION & SALES 40
5.2.4 POST-SALES REVIEW 40
5.3 INVESTMENT OPPORTUNITIES 41
6 GLOBAL THORACOLUMBAR SPINE DEVICES MARKET, BY PRODUCT TYPE
6.1 OVERVIEW 42
6.2 SPINAL IMPLANTS 44
6.3 DEVICES AND INSTRUMENTATION 44
6.4 SPINE BIOLOGICS 45
7 GLOBAL THORACOLUMBAR SPINE DEVICES MARKET, BY TYPE OF SURGERY
7.1 OVERVIEW 46
7.2 OPEN SURGERY 48
7.3 MINIMALLY INVASIVE SURGERY (MIS) 49
8 GLOBAL THORACOLUMBAR SPINE DEVICES MARKET, BY MATERIAL
8.1 OVERVIEW 50
8.2 TITANIUM 51
8.3 STAINLESS STEEL 52
8.4 BIOMATERIALS 53
8.5 OTHERS 53
9 GLOBAL THORACOLUMBAR SPINE DEVICES MARKET, BY END USER
9.1 OVERVIEW 54
9.2 HOSPITALS AND CLINICS 55
9.3 AMBULATORY SURGERY CENTERS 56
9.4 ACADEMIC INSTITUTES AND RESEARCH CENTERS 56
9.5 OTHERS 56
10 GLOBAL THORACOLUMBAR SPINE DEVICES MARKET, BY REGION
10.1 OVERVIEW 57
10.2 AMERICAS 59
10.2.1 NORTH AMERICA 61
10.2.2 LATIN AMERICA 66
10.3 EUROPE 68
10.3.1 WESTERN EUROPE 70
10.3.2 EASTERN EUROPE 80
10.4 ASIA-PACIFIC 82
10.4.1 JAPAN 84
10.4.2 CHINA 86
10.4.3 INDIA 87
10.4.4 SOUTH KOREA 88
10.4.5 AUSTRALIA 90
10.4.6 REST OF ASIA-PACIFIC 91
10.5 MIDDLE EAST & AFRICA 93
10.5.1 MIDDLE EAST 95
10.5.2 AFRICA 96
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW 98
11.2 COMPANY RANKING 98
11.3 COMPETITIVE BENCHMARKING 100
11.4 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE THORACOLUMBAR SPINE DEVICES MARKET 101
11.5 KEY DEVELOPMENT ANALYSIS 101
11.1 KEY DEVELOPMENTS & GROWTH STRATEGIES 102
11.1.1 NEW PRODUCT LAUNCH/APPROVAL 102
11.1.2 MERGERS & ACQUISITIONS 103
12 COMPANY PROFILES
12.1 ORTHOFIX HOLDINGS, INC. 104
12.1.1 COMPANY OVERVIEW 104
12.1.2 FINANCIAL OVERVIEW 105
12.1.3 PRODUCTS/SERVICES OFFERED 106
12.1.4 KEY DEVELOPMENTS 106
12.1.5 SWOT ANALYSIS 107
12.1.6 KEY STRATEGIES 107
12.2 ALPHATECH HOLDINGS, INC. 108
12.2.1 COMPANY OVERVIEW 108
12.2.2 FINANCIAL OVERVIEW 109
12.2.3 PRODUCTS/SERVICES OFFERED 109
12.2.4 KEY DEVELOPMENTS 110
12.2.5 SWOT ANALYSIS 110
12.2.6 KEY STRATEGIES 111
12.3 B. BRAUN MELSUNGEN AG 112
12.3.1 COMPANY OVERVIEW 112
12.3.2 FINANCIAL OVERVIEW 112
12.3.3 PRODUCTS/SERVICES OFFERED 113
12.3.4 KEY DEVELOPMENTS 113
12.3.5 SWOT ANALYSIS 114
12.3.6 KEY STRATEGIES 114
12.4 DEPUY SYNTHES 115
12.4.1 COMPANY OVERVIEW 115
12.4.2 FINANCIAL OVERVIEW 115
12.4.3 PRODUCTS/SERVICES OFFERED 116
12.4.4 KEY DEVELOPMENTS 116
12.4.5 SWOT ANALYSIS 117
12.4.6 KEY STRATEGIES 117
12.5 EXACTECH, INC. 118
12.5.1 COMPANY OVERVIEW 118
12.5.2 FINANCIAL OVERVIEW 118
12.5.3 PRODUCTS/SERVICES OFFERED 119
12.5.4 KEY DEVELOPMENTS 119
12.5.5 SWOT ANALYSIS 120
12.5.6 KEY STRATEGIES 120
12.6 GLOBUS MEDICAL, INC. 121
12.6.1 COMPANY OVERVIEW 121
12.6.2 FINANCIAL OVERVIEW 121
12.6.3 PRODUCTS/SERVICES OFFERED 122
12.6.4 KEY DEVELOPMENTS 122
12.6.5 SWOT ANALYSIS 123
12.6.6 KEY STRATEGIES 123
12.7 MEDTRONIC PLC 124
12.7.1 COMPANY OVERVIEW 124
12.7.2 FINANCIAL OVERVIEW 125
12.7.3 PRODUCTS/SERVICES OFFERED 125
12.7.4 KEY DEVELOPMENTS 126
12.7.5 SWOT ANALYSIS 126
12.7.6 KEY STRATEGIES 127
12.8 NUVASIVE, INC. 128
12.8.1 COMPANY OVERVIEW 128
12.8.2 FINANCIAL OVERVIEW 129
12.8.3 PRODUCTS/SERVICES OFFERED 129
12.8.4 KEY DEVELOPMENTS 130
12.8.5 SWOT ANALYSIS 130
12.8.6 KEY STRATEGIES 130
12.9 ZIMMER BIOMET HOLDINGS, INC. 131
12.9.1 COMPANY OVERVIEW 131
12.9.2 FINANCIAL OVERVIEW 132
12.9.3 PRODUCTS/SERVICES OFFERED 133
12.9.4 KEY DEVELOPMENTS 133
12.9.5 SWOT ANALYSIS 134
12.9.6 KEY STRATEGIES 134
12.10 STRYKER CORPORATION 135
12.10.1 COMPANY OVERVIEW 135
12.10.2 FINANCIAL OVERVIEW 136
12.10.3 PRODUCTS/SERVICES OFFERED 137
12.10.4 KEY DEVELOPMENTS 137
12.10.5 SWOT ANALYSIS 138
12.10.6 KEY STRATEGIES 138
13 APPENDIX
13.1 REFERENCES 139
13.2 RELATED REPORTS 139
